Skip to main content
Dan Barouch, MD, Infectious Disease, Boston, MA, Beth Israel Deaconess Medical Center

DanHBarouchMD

Infectious Disease • Boston, MA

Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Barouch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Barouch's full profile

Already have an account?

  • Office

    330 Brookline Ave
    Research East 113 Beth Israel Deaconess Hospital
    Boston, MA 02215
    Phone+1 617-667-4434
    Fax+1 617-667-8210
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2001 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine  
    Jerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine

Lectures

  • 11th Vaccines Research and Development: All Things Considered Conference 
    Global Technology Community (GTC), Boston, Massachusetts - 7/8/2013
  • Publisher Correction: Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys 
    Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

  • As Covid Emergency Ends, U.S. Response Shifts to ‘Peacetime’ Mode
    As Covid Emergency Ends, U.S. Response Shifts to ‘Peacetime’ ModeMay 10th, 2023
  • Covid-19 Experts Say They Warned White House About Chance of an Omicron-Level Event Within the Next Two Years
    Covid-19 Experts Say They Warned White House About Chance of an Omicron-Level Event Within the Next Two YearsMay 6th, 2023
  • Dr. Michael Osterholm Joins Several Infectious Disease Experts to Discuss New Coronavirus Vaccines R&D Roadmap
    Dr. Michael Osterholm Joins Several Infectious Disease Experts to Discuss New Coronavirus Vaccines R&D RoadmapApril 20th, 2023
  • Join now to see all

Grant Support

  • Consortium For AIDS Vaccine Research In Nonhuman PrimatesNational Institute Of Allergy And Infectious Diseases2011
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2011
  • Adenovirus And Poxvirus Mediated Protection Against Mucosal SIV InfectionNational Institute Of Allergy And Infectious Diseases2011
  • Metagenomics Of Enteric Disease In Siv-Infected And Uninfected MacaquesNational Center For Research Resources2011
  • Impact Of HIV Envelope Conformation On ImmunogenicityNational Institute Of Allergy And Infectious Diseases2009–2011
  • Preclinical Evaluation Of Novel Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Heterologous Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Recombinant Adenovirus Vaccine Vectors For HIV/SIV In Rhesus MonkeysNational Center For Research Resources2005–2011
  • Novel Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2006–2010
  • Preclinical Evaluation Of Novel Adenovirus VectorsNational Institute Of Allergy And Infectious Diseases2005–2009
  • Novel Adenovirus Vector-Based Vaccines For HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
  • Augmentation Of DNA Vaccine-Elicited Immunity To HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2008
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2005
  • Chimeric Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2005
  • Cytokine-Augmented DNA Vaccine-Elicited Immunity To HIVNational Institute Of Allergy And Infectious Diseases2002–2005

Hospital Affiliations

Dr. Dan Barouch, Dr. Dan Barouch, MD, Dr. D Barouch, Dr. Dan H Barouch